Government Medical College, Kozhikode, India.
Department of Medical Oncology, Basavatarakam Indo American Cancer Hospital and Research Institute, Hyderabad, India.
Lancet Oncol. 2021 Dec;22(12):e541-e549. doi: 10.1016/S1470-2045(21)00468-X.
Although financial toxicity is widely acknowledged to be a potential consequence of costly cancer treatment, little is known about its prevalence and outcome among the Indian population. In this study, we systematically reviewed the prevalence, determinants, and consequences of financial toxicity among patients with cancer in India. 22 studies were included in the systematic review. The determinants of financial toxicity include household income, type of health-care facility used, stage of disease, area of residence, age at the time of diagnosis, recurrent cancer, educational status, insurance coverage, and treatment modality. Financial toxicity was associated with poor quality of life, accumulation of debts, premature entry into the labour market, and non-compliance with therapy. Our findings emphasise the need for urgent strategies to mitigate financial toxicity among patients with cancer in India, especially in the most deprived sections of society. The qualitative evidence synthesised in this systematic review could provide a basis for the development of such interventions to reduce financial toxicity among patients with cancer.
尽管人们普遍认识到昂贵的癌症治疗可能导致财务毒性,但对于印度人群中财务毒性的流行程度和后果知之甚少。在这项研究中,我们系统地综述了印度癌症患者财务毒性的流行程度、决定因素和后果。共有 22 项研究被纳入系统综述。财务毒性的决定因素包括家庭收入、所使用的医疗保健机构类型、疾病分期、居住地区、诊断时的年龄、癌症复发、教育程度、保险覆盖范围和治疗方式。财务毒性与生活质量差、债务积累、提前进入劳动力市场以及不遵守治疗方案有关。我们的研究结果强调,印度癌症患者需要紧急采取策略来减轻财务毒性,特别是在社会最贫困的阶层。本系统综述综合的定性证据可以为制定此类干预措施提供依据,以减少癌症患者的财务毒性。